Dr. Di Pasqua is co-founder, CEO and President of DB Therapeutics, Inc. With his collaborators, he conceptualized and invented the technology of holmium-166-based radiotherapeutic bandages. Dr. Di Pasqua is also an Assistant Professor of Pharmaceutical Sciences at Binghamton University. Dr. Di Pasqua is an expert in nanomaterials and their use in chemo- and radiotherapeutics, and platinum-based anticancer agents. His research focuses on the development of novel delivery systems to enhance the efficacy of therapeutically active compounds while minimizing their side effects in patients and translating basic scientific concepts into therapeutic applications for use in the clinic.
Dr. Balkus is co-founder of DB Therapeutics, Inc. and a co-inventor of the holmium-166-based radiotherapeutic bandages. Dr. Balkus is a Professor in the Department of Chemistry at University of Texas at Dallas. His laboratory is focused on research of nanoporous metal oxides, which includes zeolites and related molecular sieves, as well as layered materials. He has also worked on preparation, modification and application of molecular sieves in the areas ranging from catalysis to chemical sensors. He brings years of material sciences expertise to the team.
Dr. Thamake is co-founder of DB Therapeutics, Inc. He has expertise in clinical development of radioisotope-based diagnostic and therapeutic agents. He received his doctorate from the University of North Texas Health Science Center at Fort Worth as well as a master’s in Clinical Research Management from the same institution. He has hands-on expertise in translation of radiotherapeutic products from bench to bedside with significant expertise in drug development. He is currently engaged in a consulting role with DB Therapeutics, Inc.
Mr. Driscoll is Chief Financial Officer for DB Therapeutics, Inc., and has been instrumental in DB Therapeutics, Inc.'s ability to acquire first round funding. He has a history of successful ventures.
Copyright © 2020 DB Therapeutics, Inc. - All Rights Reserved.